Acadian Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.6M | Sell |
102,800
-17,834
| -15% | -$5.14M | 0.04% | 325 |
|
|
2025
Q4 | $36.5M | Sell |
120,634
-18,255
| -13% | -$5.7M | 0.06% | 249 |
|
|
2025
Q3 | $38.9M | Buy |
138,889
+87,479
| +170% | +$23.8M | 0.07% | 228 |
|
|
2025
Q2 | $12.4M | Sell |
51,410
-22,021
| -30% | -$5.21M | 0.03% | 392 |
|
|
2025
Q1 | $17.9M | Buy |
73,431
+32,534
| +80% | +$9.79M | 0.05% | 245 |
|
|
2024
Q4 | $13.4M | Buy |
40,897
+39,099
| +2,175% | +$13.3M | 0.04% | 303 |
|
|
2024
Q3 | $601K | Sell |
1,798
-1,122
| -38% | -$356K | ﹤0.01% | 1043 |
|
|
2024
Q2 | $796K | Sell |
2,920
-16,144
| -85% | -$4.7M | ﹤0.01% | 1067 |
|
|
2024
Q1 | $6.59M | Sell |
19,064
-7,616
| -29% | -$2.5M | 0.02% | 399 |
|
|
2023
Q4 | $8.61M | Sell |
26,680
-8,745
| -25% | -$2.74M | 0.03% | 324 |
|
|
2023
Q3 | $12.7M | Sell |
35,425
-87,533
| -71% | -$33.8M | 0.05% | 250 |
|
|
2023
Q2 | $46.6M | Sell |
122,958
-125,578
| -51% | -$51.1M | 0.19% | 137 |
|
|
2023
Q1 | $119M | Sell |
248,536
-84,728
| -25% | -$39.7M | 0.52% | 51 |
|
|
2022
Q4 | $140M | Sell |
333,264
-59,438
| -15% | -$24M | 0.69% | 31 |
|
|
2022
Q3 | $164M | Sell |
392,702
-10,304
| -3% | -$5.14M | 0.9% | 17 |
|
|
2022
Q2 | $199M | Sell |
403,006
-12,528
| -3% | -$6.52M | 1.02% | 15 |
|
|
2022
Q1 | $234M | Buy |
415,534
+4,048
| +1% | +$2.44M | 0.96% | 15 |
|
|
2021
Q4 | $311M | Sell |
411,486
-11,389
| -3% | -$8.52M | 1.16% | 10 |
|
|
2021
Q3 | $315M | Buy |
422,875
+36,122
| +9% | +$27.1M | 1.2% | 13 |
|
|
2021
Q2 | $249M | Buy |
386,753
+97,754
| +34% | +$59.5M | 0.94% | 14 |
|
|
2021
Q1 | $165M | Buy |
288,999
+45,687
| +19% | +$27.1M | 0.64% | 36 |
|
|
2020
Q4 | $142M | Buy |
243,312
+300
| +0.1% | +$171K | 0.55% | 46 |
|
|
2020
Q3 | $125M | Sell |
243,012
-22,355
| -8% | -$11.3M | 0.52% | 51 |
|
|
2020
Q2 | $120M | Buy |
+265,367
| New | +$117M | 0.52% | 40 |
|
|
2019
Q4 | – | Sell |
-370,554
| Closed | -$123M | – | 1900 |
|
|
2019
Q3 | $123M | Buy |
+370,554
| New | +$121M | 0.53% | 49 |
|
|
2019
Q2 | – | Sell |
-513,409
| Closed | -$157M | – | 1813 |
|
|
2019
Q1 | $157M | Sell |
513,409
-105,613
| -17% | -$28.5M | 0.68% | 35 |
|
|
2018
Q4 | $144M | Sell |
619,022
-84,725
| -12% | -$22.7M | 0.71% | 33 |
|
|
2018
Q3 | $220M | Sell |
703,747
-44,269
| -6% | -$13.7M | 0.91% | 25 |
|
|
2018
Q2 | $216M | Sell |
748,016
-56,935
| -7% | -$15.7M | 0.93% | 21 |
|
|
2018
Q1 | $201M | Sell |
804,951
-27,595
| -3% | -$7.03M | 0.87% | 26 |
|
|
2017
Q4 | $199M | Sell |
832,546
-57,531
| -6% | -$13.9M | 0.86% | 25 |
|
|
2017
Q3 | $198M | Sell |
890,077
-4,109
| -0.5% | -$925K | 0.87% | 26 |
|
|
2017
Q2 | $202M | Sell |
894,186
-1,055
| -0.1% | -$230K | 0.92% | 22 |
|
|
2017
Q1 | $178M | Sell |
895,241
-34,281
| -4% | -$6.6M | 0.82% | 24 |
|
|
2016
Q4 | $169M | Sell |
929,522
-6,267
| -0.7% | -$1.07M | 0.82% | 26 |
|
|
2016
Q3 | $153M | Sell |
935,789
-7,280
| -0.8% | -$1.1M | 0.76% | 28 |
|
|
2016
Q2 | $135M | Buy |
943,069
+8,923
| +1% | +$1.27M | 0.69% | 36 |
|
|
2016
Q1 | $128M | Buy |
934,146
+390
| +0% | +$51.2K | 0.64% | 32 |
|
|
2015
Q4 | $129M | Buy |
933,756
+95,551
| +11% | +$13.2M | 0.68% | 31 |
|
|
2015
Q3 | $113M | Buy |
838,205
+251,190
| +43% | +$36.2M | 0.61% | 39 |
|
|
2015
Q2 | $88.4M | Buy |
587,015
+410,710
| +233% | +$58.8M | 0.43% | 59 |
|
|
2015
Q1 | $23.8M | Buy |
176,305
+58,103
| +49% | +$7.2M | 0.11% | 186 |
|
|
2014
Q4 | $14.2M | Buy |
118,202
+43,013
| +57% | +$4.95M | 0.06% | 244 |
|
|
2014
Q3 | $8.53M | Buy |
75,189
+58,240
| +344% | +$6.9M | 0.04% | 284 |
|
|
2014
Q2 | $2.03M | Buy |
+16,949
| New | +$2.07M | 0.01% | 499 |
|
Other funds holding BIO
VCM
VPM
AI
